<b> Auxiliary Reference List of Antithrombin Papers </b> [Added Cuomo abstract.] <b> <u>Cardiovascular/stroke</u> </b> <a href='read_msg.asp?message_id=31305782'>#msg-31305782</a> AT reduces ischemic volume (Cuomo) <a href='read_msg.asp?message_id=30287557'>#msg-30287557</a> Elevation of AT in arteriosclerosis <a href='read_msg.asp?message_id=29955598'>#msg-29955598</a> Coronary revascularization <a href='read_msg.asp?message_id=27074358'>#msg-27074358</a> Acquired AT deficiency increases risk <a href='read_msg.asp?message_id=25952778'>#msg-25952778</a> AT treatment after cardiac surgery <a href='read_msg.asp?message_id=24268577'>#msg-24268577</a> Stroke (preclinical) <a href='read_msg.asp?message_id=13345041'>#msg-13345041</a> Thrombin increases cardiomyocyte death <b> <u>DIC / Sepsis</u> </b> (A separate post accessible from the ‘ReadMeFirst’ contains the primary scientific support for ATryn in DIC/sepsis, including analysis of the KyberSept study.) <a href='read_msg.asp?message_id=29423778'>#msg-29423778</a> <b>AT MoA in sepsis</b> (full paper) <a href='read_msg.asp?message_id=27419164'>#msg-27419164</a> How the ISTH DIC score is calculated <a href='read_msg.asp?message_id=27215812'>#msg-27215812</a> <b>Scripps paper on sepsis MoA</b> <a href='read_msg.asp?message_id=29874443'>#msg-29874443</a> AT works best in medium-risk patients <a href='read_msg.asp?message_id=26018349'>#msg-26018349</a> Animal model of gram-positive septicemia <a href='read_msg.asp?message_id=25907502'>#msg-25907502</a> Pct of sepsis patients with DIC <a href='read_msg.asp?message_id=25907331'>#msg-25907331</a> Hemostatic changes <a href='read_msg.asp?message_id=25511473'>#msg-25511473</a> Ditto <a href='read_msg.asp?message_id=25480768'>#msg-25480768</a> <b>Anti-inflammatory MoA</b> <a href='read_msg.asp?message_id=24523875'>#msg-24523875</a> AT experience in ICU <a href='read_msg.asp?message_id=24518865'>#msg-24518865</a> SIRS <a href='read_msg.asp?message_id=23829730'>#msg-23829730</a> Animal model <a href='read_msg.asp?message_id=14277430'>#msg-14277430</a> Thrombomodulin in DIC <a href='read_msg.asp?message_id=29874324'>#msg-29874324</a> Meta-analysis <a href='read_msg.asp?message_id=13512229'>#msg-13512229</a> Meta-analysis <a href='read_msg.asp?message_id=13150691'>#msg-13150691</a> Animal model <a href='read_msg.asp?message_id=13102302'>#msg-13102302</a> Review re AT and APC <a href='read_msg.asp?message_id=12975208'>#msg-12975208</a> AT level has predictive value <a href='read_msg.asp?message_id=12960346'>#msg-12960346</a> Coagulation vs inflammation pathways <a href='read_msg.asp?message_id=12743571'>#msg-12743571</a> Animal model <a href='read_msg.asp?message_id=12681781'>#msg-12681781</a> ISTH score for DIC <a href='read_msg.asp?message_id=11211288'>#msg-11211288</a> Animal model of AT with tPA <a href='read_msg.asp?message_id=10232620'>#msg-10232620</a> Hemostatic changes <a href='read_msg.asp?message_id=8452794'>#msg-8452794</a> Reduction of D-dimer levels <a href='read_msg.asp?message_id=7268415'>#msg-7268415</a> ATryn itself effective in small study <b> <u>Adverse outcomes during pregnancy</u> </b> <a href='read_msg.asp?message_id=26421404'>#msg-26421404</a> Severe pre-eclampsia <a href='read_msg.asp?message_id=25630072'>#msg-25630072</a> DVT <a href='read_msg.asp?message_id=22037334'>#msg-22037334</a> <a href='read_msg.asp?message_id=9327646'>#msg-9327646</a> <a href='read_msg.asp?message_id=8988372'>#msg-8988372</a> <a href='read_msg.asp?message_id=8256536'>#msg-8256536</a> <a href='read_msg.asp?message_id=7834418'>#msg-7834418</a> <a href='read_msg.asp?message_id=7050226'>#msg-7050226</a> <b> <u>Hereditary deficiency</u> </b> <a href='read_msg.asp?message_id=25630072'>#msg-25630072</a> DVT rate (acute) <a href='read_msg.asp?message_id=24140012'>#msg-24140012</a> Lovenox doesn’t work in HD <a href='read_msg.asp?message_id=6794514'>#msg-6794514</a> DVT rate (chronic) <b> <u>Cancer</u> </b> <a href='read_msg.asp?message_id=18991235'>#msg-18991235</a> Pediatric ALL <a href='read_msg.asp?message_id=12476761'>#msg-12476761</a> Coagulation in cancer <a href='read_msg.asp?message_id=12181584'>#msg-12181584</a> Acute lymphoblastic leukemia <a href='read_msg.asp?message_id=11804544'>#msg-11804544</a> Use of anti-thrombotics in cancer <a href='read_msg.asp?message_id=9460320'>#msg-9460320</a> Liver mets in colon cancer <a href=http://www.news.harvard.edu/gazette/1999/09.23/aaat.html>AT fragment in lung-cancer model</a> <b><u>Chemistry and pharmacokinetics</u></b> <a href='read_msg.asp?message_id=13173404'>#msg-13173404</a> Covalent linkage between AT and heparin <a href='read_msg.asp?message_id=12100172'>#msg-12100172</a> PK of AT from CHO cells <a href='read_msg.asp?message_id=11801772'>#msg-11801772</a> PK of ATryn vs plasma AT <a href='read_msg.asp?message_id=30027881'>#msg-30027881</a> Ditto <a href='read_msg.asp?message_id=7669971'>#msg-7669971</a> AT glycosylation <a href='read_msg.asp?message_id=6995560'>#msg-6995560</a> AT glycosylation <b> <u> Miscellaneous </u> </b> <a href='read_msg.asp?message_id=30028400'>#msg-30028400</a> Human nephrotic syndrome <a href='read_msg.asp?message_id=28267133'>#msg-28267133</a> VOD <a href='read_msg.asp?message_id=27074306'>#msg-27074306</a> FVIII deficiency <a href='read_msg.asp?message_id=26018345'>#msg-26018345</a> Burns <a href='read_msg.asp?message_id=25590840'>#msg-25590840</a> Increasing AT yield from CHO cells <a href='read_msg.asp?message_id=25481215'>#msg-25481215</a> Acute lung injury (preclinical) <a href='read_msg.asp?message_id=25291011'>#msg-25291011</a> Ditto <a href='read_msg.asp?message_id=20210837'>#msg-20210837</a> ARDS <a href='read_msg.asp?message_id=15039853'>#msg-15039853</a> Burns <a href='read_msg.asp?message_id=14277297'>#msg-14277297</a> Polymicrobial peritonitis <a href='read_msg.asp?message_id=14199820'>#msg-14199820</a> Platelet adhesion <a href='read_msg.asp?message_id=13292817'>#msg-13292817</a> Pediatric ECMO <a href='read_msg.asp?message_id=12714409'>#msg-12714409</a> Retinal vein occlusion <a href='read_msg.asp?message_id=11611213'>#msg-11611213</a> VOD combo treatment with defibrotide <a href='read_msg.asp?message_id=11609770'>#msg-11609770</a> SPK transplantation <a href='read_msg.asp?message_id=10969504'>#msg-10969504</a> Recurrent thromboembolism risk <a href='read_msg.asp?message_id=10321740'>#msg-10321740</a> Aneurysm surgery